At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5,594 enrolled
Drug / intervention
no interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry
In Brief
An observational study evaluating no intervention for ST-segment Elevation Myocardial Infarction (STEMI). Completed, enrolled 5,594 participants across 1 site.
Detailed Summary
The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
CollaboratorsThe First College of Clinical Medical Science, China Three Gorges University, The First Affiliated Hospital of Dalian Medical University, Jiangxi Provincial People's Hopital, The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Xiangyang No.1 People's Hospital, Wuhan Third Hospital
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartMay 2021
First PostedAug 2021
Primary CompletionDec 2021
TodayJul 2026
First PostedAug 9, 2021
Enrollment StartMay 22, 2021
Primary CompletionDec 5, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.9 years ago
Interventions
no interventionother
no intervention